| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 663285 | 6-N-(Aminoethyl-2-(4-morpholino))-6-chloro-5,8-quinolinedione | 0.00293992674122322 | 0.38965416 |
| NSC 670404 | Null | 0.00293992674122322 | 0.33886868 |
| NSC 683416 | 1H-Pyrrole-2-carboxamide, N-[2-[[[4-[[5,5a,6,8,8a,9-hexahydro- 5-(4-hydroxy-3,5-dimethoxyphenyl)- 6-oxofuro[3',4':6,7]naphtho[1,2-d]-1,3-dioxol-9-yl]amino] phenyl]amino]carbonyl]-1-methyl-1H-pyrrol-4 | 0.00293992674122322 | 0.42912178 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.00352002370824893 | 0.34755689 |
| NSC 67588 | 2-Naphthacenecarboxamide, 4-dimethylamino-1,4,4a,5,5a,6,11,12a-pentahydroxy-N-[6-mercaptopurin-7(or 9)-ylmethyl]-6-methyl-1,11-dioxo- | 0.00352002370824893 | 0.20938607 |
| NSC 734626 | Null | 0.00352002370824895 | 0.21795119 |
| NSC 743430 | 2-{4-[4-(4-{4-[6-(4-methyl piperazino)-1H-benzo[d]imidazole-2-yl]phenoxy}butyl)piperazino]butyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione | 0.00352002370824895 | 0.15771283 |
| NSC 696990 | Null | 0.00397405528023193 | 0.36398914 |
| NSC 716089 | Null | 0.00397405528023193 | 0.32506996 |
| NSC 725191 | 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol | 0.00397405528023193 | 0.48697475 |